1-4 of 4
Parameswaran N. Hari, MD, MS
Close
Sort by
Journal Articles

Response to Bortezomib Based Induction Therapy in Newly Diagnosed Light Chain (AL) Amyloidosis.

Veerpal Singh, MD, Ayman Saad, MD, Jeanne Palmer, MD, Jasleen K Randhawa, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 1867.
https://doi.org/10.1182/blood.V114.22.1867.1867
Published: 2009
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (HCT) is a Safe and Effective Treatment for Primary Plasma Cell Leukemia: The CIBMTR Experience.

Anuj Mahindra, MD, David Vesole, MD, PhD, Matt E. Kalaycio, MD, Jorge Vela-Ojeda, MD, Smriti Shrestha, MS, MA, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 532.
https://doi.org/10.1182/blood.V114.22.532.532
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplantation (SCT) for Multiple Myeloma (MM) - What Has Changed? : A CIBMTR Analysis From 1989 – 2005.

Shaji Kumar, MD, Smriti Shrestha, MS, MA, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 54.
https://doi.org/10.1182/blood.V114.22.54.54
Published: 2009
Journal Articles

High Prevalence of Dapsone-Induced Oxidant Hemolysis in North American Stem Cell Transplant Recipients without Glucose-6-Phosphate-Dehydrogenase Deficiency.

Horatiu Olteanu, MD, PhD, Alexandra Harrington, MD, Ben George, MD, Christopher Bredeson, MD, Parameswaran N. Hari, MD, MS, Steven Kroft, MD
Journal: Blood
Blood (2009) 114 (22): 3314.
https://doi.org/10.1182/blood.V114.22.3314.3314
Published: 2009